The stock of ReNeuron Group Plc (LON:RENE) is a huge mover today! The stock increased 5.20% or GBX 0.13 on November 22, hitting GBX 2.63. About 1.90M shares traded hands. ReNeuron Group Plc (LON:RENE) has declined 20.00% since April 21, 2016 and is downtrending. It has underperformed by 24.56% the S&P500.
The move comes after 7 months positive chart setup for the GBX 82.36M company. It was reported on Nov, 22 by Barchart.com. We have GBX 2.81 PT which if reached, will make LON:RENE worth GBX 5.77 million more.
More news for ReNeuron Group Plc (LON:RENE) were recently published by: Uk.Finance.Yahoo.com, which released: “ReNeuron Group plc (RENE.L)” on March 29, 2014. Fool.Co.Uk‘s article titled: “Is ReNeuron Group Plc The Perfect Partner For BTG plc And Shire PLC In Your …” and published on June 22, 2015 is yet another important article.
ReNeuron Group plc is a clinical-stage company. The company has a market cap of 82.36 million GBP. The Company, through its subsidiaries, is engaged in researching and developing cell therapies. It currently has negative earnings. The Company’s products are allogeneic.